BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Facciorusso A, Del Prete V, Crucinio N, Serviddio G, Vendemiale G, Muscatiello N. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. World J Gastroenterol 2016; 22(16): 4211-4218 [PMID: 27122671 DOI: 10.3748/wjg.v22.i16.4211]
URL: https://www.wjgnet.com/1007-9327/full/v22/i16/4211.htm
Number Citing Articles
1
Takuya Tajiri, Kosuke Mima, Toru Beppu, Hiromitsu Hayashi, Taichi Horino, Yuki Adachi, Katsunori Imai, Toshiro Masuda, Yuji Miyamoto, Masaaki Iwatsuki. RAS-Beppu Classification: A New Recurrence Risk Classification System Incorporating the Beppu Score and RAS Status for Colorectal Liver Metastases. Cancers 2025; 17(4) doi: 10.3390/cancers17040640
2
Ming Yang, Yilin Pan, Wentao Wang. Prognostic significance of the CRAFITY score in hepatocellular carcinoma treated with immunotherapy: a systematic review and meta-analysis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10686-9
3
Dewen Tan, Yan Fu, Weidong Tong, Fan Li. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis. International Journal of Surgery 2018; 55 doi: 10.1016/j.ijsu.2018.05.030
4
Yaqi Zhang, Yujing He, Ziyu Wang, Yingke Sun, Haijie Zhi, Hongliang Wu, Bingtao Weng, Zhangfa Song. Integration of Preoperative Neutrophil-to-Lymphocyte Ratio into Machine Learning Models for Predicting Lymph Node Metastasis in CRC. Cancers 2026; 18(15) doi: 10.3390/cancers18152370
5
Huanlei Zhang, Ying Zou, Fengyue Tian, Wenfei Li, Xiaodong Ji, Yu Guo, Qing Li, Shuangyan Sun, Fang Sun, Lianfang Shen, Shuang Xia. Dual-energy CT may predict post-operative recurrence in early-stage glottic laryngeal cancer: a novel nomogram and risk stratification system. European Radiology 2022; 32(3) doi: 10.1007/s00330-021-08265-2
6
Yiru Zhang, Qigu Yao, Yong Pan, Xinru Fang, Haoying Xu, Tingxiao Zhao, Guangqi Zhu, Tianan Jiang, Shibo Li, Hongcui Cao. Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review. Cancers 2023; 15(3) doi: 10.3390/cancers15030682
7
Pingping Mei, Li Huang, Lu Lin, Yan Chen, Xiutian Guo. The prognostic utility of the ratio of lymphocyte to monocyte in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1394154
8
Koji Tomita, Yusuke Matsui, Mayu Uka, Noriyuki Umakoshi, Takahiro Kawabata, Kazuaki Munetomo, Shoma Nagata, Toshihiro Iguchi, Takao Hiraki. Evidence on percutaneous radiofrequency and microwave ablation for liver metastases over the last decade. Japanese Journal of Radiology 2022; 40(10) doi: 10.1007/s11604-022-01335-5
9
Lianlei Yang, Adil Manzoor Bhat, Sahar Qazi, Khalid Raza. DLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study. Medicina 2023; 59(3) doi: 10.3390/medicina59030514
10
Toshiro Masuda, Toru Beppu, Hirohisa Okabe, Katsunori Imai, Hiromitsu Hayashi. How Can We Improve the Survival of Patients with Colorectal Liver Metastases Using Thermal Ablation?. Cancers 2025; 17(2) doi: 10.3390/cancers17020199
11
Che Muhammad Khairul Hisyam Bin Ismail, Edre Bin Mohammad Aidid, Hairul Aini Binti Hamzah, Mohd Shaiful Ehsan Bin Shalihin, Azmi Bin Md Nor. Streptococcus gallolyticus infection: A neglected marker for colorectal cancer?. Arab Journal of Gastroenterology 2023; 24(3) doi: 10.1016/j.ajg.2023.02.002
12
Xin He, Yong-qiang Jiao, Xiong-gang Yang, Yong-cheng Hu. A Novel Prediction Tool for Overall Survival of Patients Living with Spinal Metastatic Disease. World Neurosurgery 2020; 144 doi: 10.1016/j.wneu.2020.09.081
13
Li Fei, Xing Hongsong. Effectiveness of microwave ablation for the treatment of hepatic hemangioma - meta-analysis and meta-regression. International Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2022.2146214
14
Ketong Wu, Haiyang Chen, Dan Li, Yuan Wan, Weiyao Li, Bo Zhang. Treatment Patterns and Prognostic Nomograms for Overall Survival and Hepatic Progression-Free Survival in Unresectable Colorectal Liver Metastases Treated with Drug-Eluting Bead Chemoembolization: A Single-Center Study. Current Oncology 2026; 33(9) doi: 10.3390/curroncol33090497
15
Pingping Mei, Wenzhe Feng, Yanrong Zhan, Xiutian Guo. Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1321584
16
Pujitha Kudaravalli, Sahib Singh, Rakesh Vinayek, Ganesh Aswath, Stefano Francesco Crinò, Jorge Machicado, Antonio Facciorusso. Reducing the incidence of pancreatic cancer through radiofrequency ablation of mucinous cystic neoplasms: What is the evidence?. Best Practice & Research Clinical Gastroenterology 2025; 74 doi: 10.1016/j.bpg.2025.101986
17
Stergios Boussios, Mehmet Ozturk, Michele Moschetta, Afroditi Karathanasi, Nikolaos Zakynthinakis-Kyriakou, Konstantinos Katsanos, Dimitrios Christodoulou, Nicholas Pavlidis. The Developing Story of Predictive Biomarkers in Colorectal Cancer. Journal of Personalized Medicine 2019; 9(1) doi: 10.3390/jpm9010012
18
Brian I. Carr, Harika Gozukara Bag, Volkan Ince, Sami Akbulut, Veysel Ersan, Sertac Usta, Burak Isik, Zeki Ogut, Adem Tuncer, Sezai Yilmaz. A Combination of Blood Lymphocytes and AST Levels Distinguishes Patients with Small Hepatocellular Carcinomas from Non-cancer Patients. Journal of Gastrointestinal Cancer 2021; 52(4) doi: 10.1007/s12029-021-00740-9
19
Lin-Lin Liu, Jun-Die Sun, Zuo-Lin Xiang. Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02547-9
20
Yiming Mao, Donglai Chen, Shanzhou Duan, Yuhuan Zhao, Changjiang Wu, Feng Zhu, Chang Chen, Yongbing Chen. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0698-5
21
Kazuto Tajiri, Nozomu Muraishi, Eiki Ishizaka, Aiko Murayama, Yuka Hayashi, Ichiro Yasuda. On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma. Cancers 2026; 18(6) doi: 10.3390/cancers18061021
22
Wentao Li, Yue Lou, Guangzhi Wang, Kangwei Zhang, Lichao Xu, Ping Liu, Lisa X. Xu. A Novel Multi-Mode Thermal Therapy for Colorectal Cancer Liver Metastasis: A Pilot Study. Biomedicines 2022; 10(2) doi: 10.3390/biomedicines10020280
23
Yong Wu, Bo Xu, Sheng Hu, Bi-Bo Shao. Risk factors for and predictive nomogram of overall survival in adult patients with craniopharyngiomas: A SEER population-based study. Medicine 2022; 101(26) doi: 10.1097/MD.0000000000029777
24
Jian-Xu Li, Mei-Ling He, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Jian-Hong Zhong, Rui-Jun Zhang, Chun-Feng Liang, Ya-Dan Pang, Jun-Kun He, Qian-Qian Chen, Jin-Xia Weng, Shi-Xiong Liang, Bang-De Xiang. Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02596-0
25
Rodolfo Sacco, Daryl Ramai, Raffaella Tortora, Giovan Giuseppe di Costanzo, Michela Emma Burlone, Mario Pirisi, Piera Federico, Bruno Daniele, Marianna Silletta, Paolo Gallo, Caterina Cocuzza, Maurizio Russello, Giuseppe Cabibbo, Gabriele Rancatore, Silvia Cesario, Gianluca Masi, Luca Marzi, Andrea Mega, Alessandro Granito, Giulia Pieri, Edoardo G. Giannini, Rosa Paolillo, Gennaro Gadaleta-Caldarola, Vincenzo Dadduzio, Guido Giordano, Luca Giacomelli, Simonetta Papa, Matteo Renzulli, Marcello Maida, Michele Ghidini, Mauro Borzio, Antonio Facciorusso. Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. Cancers 2023; 15(2) doi: 10.3390/cancers15020381
26
Nicole J. Kim, Jessica H. Yoon, Adam C. Tuomi, John Lee, Daehee Kim. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1118845
27
Dashuai Yang, Yang Su, Fangrui Zhao, Yong Hu, Kailiang Zhao, Xiangyun Xiong, Mingqiang Zhu, Junpeng Pei, Youming Ding. Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study. Expert Review of Gastroenterology & Hepatology 2022; 16(11-12) doi: 10.1080/17474124.2022.2150610
28
Joseph P. Erinjeri, Gabriel C. Fine, Gosse J. Adema, Muneeb Ahmed, Julius Chapiro, Martijn den Brok, Rafael Duran, Stephen J. Hunt, D. Thor Johnson, Jens Ricke, Daniel Y. Sze, Beau Bosko Toskich, Bradford J. Wood, David Woodrum, S. Nahum Goldberg. Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper. Radiology 2019; 292(1) doi: 10.1148/radiol.2019182326
29
Zhun Wang, Shuanghe Peng, Aixiang Wang, Hui Xie, Linpei Guo, Ning Jiang, Yuanjie Niu. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma. Clinica Chimica Acta 2018; 480 doi: 10.1016/j.cca.2018.02.014
30
Mario Leporace, Ferdinando F. Calabria, Roberto Siciliano, Carlo Capalbo, Dimitrios K. Filippiadis, Roberto Iezzi. The Thermal Ablation with MRgFUS: From Physics to Oncological Applications. Cancers 2024; 17(1) doi: 10.3390/cancers17010036
31
Lilong Zhang, Jiarui Feng, Tianrui Kuang, Dongqi Chai, Zhendong Qiu, Wenhong Deng, Keshuai Dong, Kailiang Zhao, Weixing Wang. Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies. International Immunopharmacology 2023; 118 doi: 10.1016/j.intimp.2023.110019
32
Mahmoud Singer, Zhuoli Zhang, Farshid Dayyani, Zigeng Zhang, Vahid Yaghmai, April Choi, Jennifer Valerin, David Imagawa, Nadine Abi-Jaoudeh. Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment. Cancers 2024; 17(1) doi: 10.3390/cancers17010066
33
Warakorn Jaseanchiun, Hiroyuki Kato, Chutima Phettool, Chanchai Suwannakij, Jadsada Athigakunagron, Setthasiri Pantanakul, Papanun Methakittrakoon, Nattapon Passawart, San Wattanasuttivong, Chaninart Liengudom, Karun Sereeborwornthanasa, Panot Yimchareon. Treatment Allocation and Survival Outcomes in Potentially Resectable Colorectal Liver Metastases: A Real-World Cohort Study from Thailand. Cancers 2026; 18(19) doi: 10.3390/cancers18193096
34
Amanda D. Morgan, Daryl Ramai, Praneeth Bandaru, Stefano Francesco Crino, Antonio Facciorusso. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(11) doi: 10.2174/1871530323666230411141412
35
Shi-hao Wang, Lei Song, Ji-yan Tang, Wei-peng Sun, Zhen Li. Safety and long-term prognosis of simultaneous versus staged resection in synchronous colorectal cancer with liver metastasis: a systematic review and meta-analysis. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00937-z
36
Qianle Cheng, Dengke Jia, Yawu Zhang. Prognostic Value of Preoperative Neutrophil Percentage to Albumin Ratio in Patients with Hepatocellular Carcinoma. Gastroenterology Insights 2026; 17(2) doi: 10.3390/gastroent17020029
37
Wei Song, Chuan Tian, Kai Wang, Run-jin Zhang, Shu-bing Zou, Flavio Rocha. Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis. PLOS ONE 2017; 12(6) doi: 10.1371/journal.pone.0178762
38
Christoph G. Radosa, Ralf-Thorsten Hoffmann. Thermoablation. Der Radiologe 2020; 60(8) doi: 10.1007/s00117-020-00719-w
39
Bin-bin Jiang, Kun Yan, Zhong-yi Zhang, Wei Yang, Wei Wu, Shan-shan Yin, Min-hua Chen. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation. International Journal of Hyperthermia 2019; 36(1) doi: 10.1080/02656736.2018.1556818
40
Panagiotis Paliogiannis, Simona Deidda, Svilen Maslyankov, Tsvetelina Paycheva, Ahmed Farag, Abdrabou Mashhour, Evangelos Misiakos, Dimitrios Papakonstantinou, Michal Mik, Joanna Losinska, Fabrizio Scognamillo, Fabio Sanna, Claudio Francesco Feo, Giuseppe Cherchi, Andreas Xidas, Angelo Zinellu, Angelo Restivo, Luigi Zorcolo. Blood cell count indexes as predictors of anastomotic leakage in elective colorectal surgery: a multicenter study on 1432 patients. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01856-1
41
Massimiliano Salati, Michele Ghidini, Matteo Paccagnella, Luca Reggiani Bonetti, Alessandro Bocconi, Andrea Spallanzani, Fabio Gelsomino, Francesca Barbin, Ornella Garrone, Bruno Daniele, Massimo Dominici, Antonio Facciorusso, Angelica Petrillo. Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience. International Journal of Molecular Sciences 2023; 24(1) doi: 10.3390/ijms24010813
42
Duilio Pagano, Vincenza Barresi, Alessandro Tropea, Antonio Galvano, Viviana Bazan, Adele Caldarella, Cristina Sani, Gianpaolo Pompeo, Valentina Russo, Rosa Liotta, Chiara Scuderi, Simona Mercorillo, Floriana Barbera, Noemi Di Lorenzo, Agita Jukna, Valentina Carradori, Monica Rizzo, Salvatore Gruttadauria, Marco Peluso. Clinical Validation of a Machine Learning-Based Biomarker Signature to Predict Response to Cytotoxic Chemotherapy Alone or Combined with Targeted Therapy in Metastatic Colorectal Cancer Patients: A Study Protocol and Review. Life 2025; 15(2) doi: 10.3390/life15020320
43
Xishu Wang, Ximin Sun, Yongrong Lei, Jun Pei, Kuansheng Ma, Kai Feng, Wan Yee Lau, Feng Xia. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study. Journal of Investigative Surgery 2023; 36(1) doi: 10.1080/08941939.2022.2130482
44
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade. Expert Review of Gastroenterology & Hepatology 2022; 16(9) doi: 10.1080/17474124.2022.2117156
45
Yu-Wei Chen, Matthew D. Tucker, Landon C. Brown, Hesham A. Yasin, Kristin K. Ancell, Andrew J. Armstrong, Kathryn E. Beckermann, Nancy B. Davis, Michael R. Harrison, Elizabeth G. Kaiser, Renee K. McAlister, Kerry R. Schaffer, Deborah E. Wallace, Daniel J. George, W. Kimryn Rathmell, Brian I. Rini, Tian Zhang. The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. Cancers 2022; 14(15) doi: 10.3390/cancers14153830
46
Qichen Chen, Mingxia Li, Jinghua Chen, Zhen Huang, Xiao Chen, Hong Zhao, Jianqiang Cai. AST·MLR index and operation injury condition are novel prognostic predictor for the prediction of survival in patients with colorectal cancer liver metastases undergoing surgical resection. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10009-4
47
Rishav Agrawal, Anthony J. Choi. Recurrence of Colorectal Cancer After Liver Transplant for Isolated Colorectal Liver Metastases: A Narrative Review. Cancers 2026; 18(9) doi: 10.3390/cancers18091450
48
Jiabing Wang, Haoqian Xu, Ying Wang, Long Feng, Fengming Yi, José L. Mauriz. Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer. Canadian Journal of Gastroenterology and Hepatology 2023; 2023 doi: 10.1155/2023/5492931
49
Laura Banias, Ioan Jung, Rebeca Chiciudean, Simona Gurzu. From Dukes-MAC Staging System to Molecular Classification: Evolving Concepts in Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23169455
50
Jakub Franke, Grzegorz Rosiak, Krzysztof Milczarek, Dariusz Konecki, Emilia Wnuk, Andrzej Cieszanowski. Biomarkers of Survival in Patients with Colorectal Liver Metastases Treated with Percutaneous Microwave Ablation. Cancers 2025; 17(7) doi: 10.3390/cancers17071112
51
Jingwen Zhang, Lishan Chen, Rui Zhou, Huiying Sun, Yulin Liao, Wangjun Liao. Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/9801063
52
Y.‐J. Cai, J.‐J. Dong, J.‐Z. Dong, Y. Chen, Z. Lin, M. Song, Y.‐Q. Wang, Y.‐P. Chen, K.‐Q. Shi, M.‐T. Zhou. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute‐on‐chronic liver failure. Alimentary Pharmacology & Therapeutics 2017; 45(11) doi: 10.1111/apt.14046
53
Cheng-gang Pang, Xiong-gang Yang, Yun-long Zhao, Yan-cheng Liu, Yong-cheng Hu. A novel tool for predicting the survival of endoprosthesis used for reconstruction of the knee following tumor resection: a retrospective cohort study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08710-x
54
Andrew R. Kolarich, Iakovos Theodoulou, Christos Georgiades. Combination Therapies with Ablation: Immunoablation. Digestive Disease Interventions 2020; 4(04) doi: 10.1055/s-0040-1721453
55
Biwei Luo, Linsen Liu, Jian’gang Bi, Shiyun Bao, Yusen Zhang. Role of the pre- to postoperative alpha-fetoprotein ratio in the prognostic evaluation of liver cancer after radiofrequency ablation. The International Journal of Biological Markers 2022; 37(3) doi: 10.1177/03936155221101075
56
Simon J. McCluney, Alexandros A. Giakoustidis, Angela Segler, Juliane Bissel, Robert L. Miller, Roberto Valente, Robert R. Hutchins, Ajit Abraham, Satyajit Bhattacharya, Hemant M. Kocher. Predicting complications in hepatic resection for colorectal liver metastasis: the lymphocyte‐to‐monocyte ratio. ANZ Journal of Surgery 2018; 88(11) doi: 10.1111/ans.14725
57
Simeon J. S. Ruiter, Pascale Tinguely, Iwan Paolucci, Jennie Engstrand, Daniel Candinas, Stefan Weber, Robbert J. de Haas, Koert P. de Jong, Jacob Freedman. 3D Quantitative Ablation Margins for Prediction of Ablation Site Recurrence After Stereotactic Image-Guided Microwave Ablation of Colorectal Liver Metastases: A Multicenter Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.757167
58
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet. Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 2022; 11(1) doi: 10.3390/biomedicines11010083
59
Jie Chai, Kaicai Liu, Dong Lu, Weifu Lv, Senlin Chu, Delei Cheng, Beibei Xu, Lijun Wang. Clinical Effectiveness of Transcatheter Arterial Chemoembolization Sequential Microwave Ablation For Lack of Blood Supply in Hepatocellular Carcinoma. Future Oncology 2022; 18(36) doi: 10.2217/fon-2022-0795
60
Yi Han, Wangyang Zhao, Min Wu, Yingjun Qian. Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis. Medicine 2022; 101(51) doi: 10.1097/MD.0000000000032304
61
Rihab Nasr, Miza Salim Hammoud, Farah Nassar, Deborah Mukherji, Ali Shamseddine, Sally Temraz. Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients. International Journal of Molecular Sciences 2018; 19(7) doi: 10.3390/ijms19071867
62
Catalin Vladut Ionut Feier, Melania Veronica Ardelean, Calin Muntean, Alaviana Monique Faur, Vasile Gaborean, Marius Sorin Murariu. Preoperative Inflammatory Markers (NLR, MLR, PLR) in Evaluating Acute Cholecystitis Severity and Operative Difficulty. Life 2026; 16(4) doi: 10.3390/life16040565
63
Elif Sertesen Çamöz, Ahmet Bayrak, Cengiz Karaçin, Şahap Törenek, İlknur Deliktaş Onur, Tuğba Önder, Öztürk Ateş. Local Ablative Therapy in Breast Cancer Liver Metastases: Survival Outcomes and Prognostic Factors—A Single-Center Retrospective Study. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114045